Spencer Fane was pleased to serve as a partner for the 5th Annual Intellectual Property Industry Forum (iPiF) March 31-April 2 in Hangzhou, China. Attorneys Jeremy Lowe and Ya-Chiao Chang presented at the event.
Jeremy led a presentation for the conference’s Pharmaceutical IP sub-forum on Winning After Losing: Redesign Under the Hatch-Waxman Act and BPCIA. The session, which continued his discussion from Pharma IPR India earlier this year, explored IP and pharmaceutical litigation under the Hatch-Waxman Act and Biologics Price Competition and Innovation Act with a focus on redesign strategies for drug and biologics companies.
Later, Ya-Chiao presented Proactive Response to Overseas NPE Litigation and Risk Control Systems as part of the Semiconductor IP sub-forum. He delved into how companies can handle the challenge of non‑practicing entity (NPE) patent lawsuits filed abroad. Topics included internal risk‑monitoring, early‑warning, and response systems to reduce exposure and manage litigation strategically.
At the firm, Jeremy leads the Spencer Fane Patent Litigation group and Hatch-Waxman and Biologics Litigation group, representing clients as first chair in complex patent trials and appeals and also providing strategic counsel on regulatory compliance. With over 27 years of experience, he is a Fellow of the Litigation Counsel of America, Order of Certus, Barrister – an honor reserved for the top 0.5% of lawyers, judges, and legal scholars.
Ya-Chiao represents U.S. and international companies – particularly those based in Taiwan and mainland China – in complex, high-stakes intellectual property matters, with a specific focus on litigating patents for traditional and emerging electronics, wireless communications, semiconductors, and other technologies. He specializes in analyzing the unique intersecting and diverging components of U.S. and Chinese patent and trademark laws, then applying his insights to develop robust plans that meet clients’ specific goals and objectives.